πŸ‡ΊπŸ‡Έ FDA
Patent

US 11344538

Methods for the treatment of myopia

granted A61KA61K31/131A61K31/439

Quick answer

US patent 11344538 (Methods for the treatment of myopia) held by Lenz Therapeutics, Inc. expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lenz Therapeutics, Inc.
Grant date
Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/131, A61K31/439, A61K31/498, A61K47/10